NeuroPace (NPCE) Selling, General & Administrative (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 349.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 351.80 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 4.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.84 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 15.10 Mn |
| Dec 31, 2023 | 13.22 Mn |
| Sep 30, 2023 | 13.39 Mn |
| Jun 30, 2023 | 14.48 Mn |
| Mar 31, 2023 | 13.43 Mn |
| Dec 31, 2022 | 13.57 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 12.77 Mn |
| Mar 31, 2022 | 12.44 Mn |
| Dec 31, 2021 | 11.75 Mn |
| Sep 30, 2021 | 9.42 Mn |
| Jun 30, 2021 | 9.53 Mn |
| Mar 31, 2021 | 8.27 Mn |
| Dec 31, 2020 | 7.28 Mn |
| Sep 30, 2020 | 7.05 Mn |
| Jun 30, 2020 | 5.62 Mn |
| Mar 31, 2020 | 7.68 Mn |